Local Institution

Jakarta 13310

0 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Bladder Cancer, Bladder Neoplasms, Chronic Disease, HIV, HIV Infections, Hepatitis B, Hepatitis B, Chronic, Kidney Neoplasms, Metastasis, Neoplasm, Bladder, Transitional Cell Carcinoma

Studies at this site

• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus — Completed
• Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation — Completed
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
• Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection — Completed
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed